Page last updated: 2024-11-12

quininone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

quininone: RN given refers to cpd without isomeric designation; converted from quinidine by resting cells of Hansenula anomala [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10969332
SCHEMBL ID2894266
MeSH IDM0191828

Synonyms (17)

Synonym
quininone
cinchonan-9-one, 6'-methoxy-, (8alpha)-
84-31-1
unii-956671ajg7
956671ajg7 ,
nsc 15307
(8alpha)-6'-methoxycinchonan-9-one
einecs 201-524-4
cinchonan-9-one, 6'-methoxy-, (8.alpha.)-
icq-15
quininone [mi]
quininone [usp-rs]
SCHEMBL2894266
[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanone
Q27271744
quininone (50 mg)
DTXSID70871567
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.08 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]